Author:
Flores-Mejía R.,Fragoso-Vázquez M. J.,Pérez-Blas L. G.,Parra-Barrera A.,Hernández-Castro S. S.,Estrada-Pérez A. R.,Rodrígues J.,Lara-Padilla E.,Ortiz-Morales A.,Correa-Basurto J.
Abstract
AbstractGeneration 4 of polyamidoamine dendrimer (G4-PAMAM) has several biological effects due to its tridimensional globular structure, repetitive branched amides, tertiary amines, and amino-terminal subunit groups liked to a common core. G4-PAMAM is cytotoxic due to its positive charges. However, its cytotoxicity could increase in cancer cells due to the excessive intracellular negative charges in these cells. Furthermore, this work reports G4-PAMAM chemical structural characterization using UHPLC-QTOF-MS/MS (LC–MS) by electrospray ionization to measure its population according to its positive charges. Additionally, the antiproliferative effects and intracellular localization were explored in the HMC-1 and K-562 cell lines by confocal microscopy. The LC–MS results show that G4-PAMAM generated multivalent mass spectrum values, and its protonated terminal amino groups produced numerous positive charges, which allowed us to determine its exact mass despite having a high molecular weight. Additionally, G4-PAMAM showed antiproliferative activity in the HMC-1 tumor cell line after 24 h (IC50 = 16.97 µM), 48 h (IC50 = 7.02 µM) and 72 h (IC50 = 5.98 µM) and in the K-562 cell line after 24 h (IC50 = 15.14 µM), 48 h (IC50 = 14.18 µM) and 72 h (IC50 = 9.91 µM). Finally, our results showed that the G4-PAMAM dendrimers were located in the cytoplasm and nucleus in both tumor cell lines studied.
Funder
Consejo Nacional de Ciencia y Tecnología
Publisher
Springer Science and Business Media LLC
Reference42 articles.
1. Tomalia, D. A., Naylor, A. M. & Goddard, W. A. III. Starburst dendrimers: molecular-level control of size, shape, surface chemistry, topology, and flexibility from atoms to macroscopic matter. Angew. Chem. Int. Ed. 29(2), 138–175 (1990).
2. Dias, A. P. et al. Dendrimers in the context of nanomedicine. Int. J. Pharm. 573, 118814 (2020).
3. Mignani, S. et al. Bench-to-bedside translation of dendrimers Reality or utopia? A concise analysis. Adv. Drug Deliv. Rev. 136–137, 73–81 (2018).
4. Madaan, K., Kumar, S., Poonia, N., Lather, V. & Pandita, D. Dendrimers in drug delivery and targeting: drug dendrimer interactions and toxicity issues. J. Pharm. Bioallied Sci. 6(3), 139–150 (2014).
5. Liu, J. et al. Novel peptide dendrimer conjugated as drug carriers for targeting nonsmall cell cancer. Int. J. Nanomed. 6, 59–69 (2011).
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献